Yamada Shigeru, Takiyama Hirotoshi, Isozaki Yuka, Shinoto Makoto, Makishima Hirokazu, Yamamoto Naoyoshi, Tsuji Hiroshi
QST Hospital, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
J Anus Rectum Colon. 2021 Apr 28;5(2):113-120. doi: 10.23922/jarc.2020-082. eCollection 2021.
Heavy-ion radiotherapy (RT) is a kind of particle RT, and carbon-ion beam constitutes the primary delivery method of heavy-ion RT. Unlike the conventional photon modalities, particle RT, in particular carbon-ion radiotherapy (CIRT), offers unique physical and biological advantages. Particle therapy allows for substantial dose delivery to tumors with minimal surrounding tissue damage. In addition, CIRT in particular possesses biological advantages such as inducing increased double-strand breaks in DNA structures, causing irreversible cell damage independently of cell cycle or oxygenation, more so than proton or photon. It can be expected that CIRT is effective on radioresistant cancers such as colorectal cancers (CRCs). We introduced the results of CIRT for local recurrent rectal cancer, lung metastasis, liver metastasis, and lymph node metastasis.
重离子放射治疗(RT)是一种粒子放射治疗,碳离子束是重离子放射治疗的主要输送方式。与传统光子模态不同,粒子放射治疗,特别是碳离子放射治疗(CIRT),具有独特的物理和生物学优势。粒子治疗能够在对周围组织损伤最小的情况下向肿瘤大量输送剂量。此外,尤其是CIRT具有生物学优势,例如在DNA结构中诱导更多双链断裂,独立于细胞周期或氧合作用导致不可逆的细胞损伤,比质子或光子更甚。可以预期CIRT对结直肠癌(CRC)等放射抗拒性癌症有效。我们介绍了CIRT用于局部复发性直肠癌、肺转移、肝转移和淋巴结转移的结果。